2023-09-05 OTCPKPHBI Press Release Pharmagreen Biotech Inc - Stockhouse Publishing
PHBI Stock | USD 0 0.0001 5.88% |
Under 51% of Pharmagreen Biotech's traders are presently thinking to get in. The analysis of overall sentiment of trading Pharmagreen Biotech pink sheet suggests that some investors are interested at this time. Pharmagreen Biotech's investing sentiment shows overall attitude of investors towards Pharmagreen Biotech.
Pharmagreen |
2023-09-05 OTCPKPHBI Press Release Pharmagreen Biotech Inc Stockhouse Publishing
Read at news.google.com
Pharmagreen Biotech Fundamental Analysis
We analyze Pharmagreen Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmagreen Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmagreen Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Pharmagreen Biotech is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Peers
Trending Equities
Complementary Tools for Pharmagreen Pink Sheet analysis
When running Pharmagreen Biotech's price analysis, check to measure Pharmagreen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagreen Biotech is operating at the current time. Most of Pharmagreen Biotech's value examination focuses on studying past and present price action to predict the probability of Pharmagreen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagreen Biotech's price. Additionally, you may evaluate how the addition of Pharmagreen Biotech to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |